My Bibliography

select

Paul S, Nishiyama Y, inventors. Covalent Bioscience, Inc., assignee. Proteolytic and Covalent Antibodies. Europe EP 1615946. 2020 May.

select

Planque SA, Massey RJ, Paul S. Catalytic antibody (catabody) platform for age-associated amyloid disease: From Heisenberg's uncertainty principle to the verge of medical interventions. Mech Ageing Dev. 2020 Jan;185:111188. doi: 10.1016/j.mad.2019.111188. Epub 2019 Nov 26. Review. PubMed PMID: 31783036; PubMed Central PMCID: PMC6938548.

select

Paul S, Planque S, Nishiyama Y, Brown EL, Smith KC, Taguchi H, inventors. Covalent Bioscience, Inc., assignee. Catalytic Antibodies against HIV gp120. Europe EP 2190875A1. 2019 July.

select

Paul S, Planque S, Nishiyama Y, Brown EL, Smith KC, Taguchi H, inventors. Covalent Bioscience, Inc., assignee. Immunoglobulins Directed to Bacterial Viral and Endogenous Polypeptides. Europe EP 19185357.1. 2019 July.

select

Paul S, Planque S, Nishiyama Y, Brown EL, Smith KC, Taguchi H, inventors. Covalent Bioscience, Inc., assignee. Immunoglobulins Directed to Bacterial Viral and Endogenous Polypeptides. United States US 15/978,801. 2018 May.

select

Paul S, Planque S, Nishiyama Y, Brown EL, Smith KC, Taguchi H, inventors. Covalent Bioscience, Inc., assignee. Immunoglobulins Directed to Bacterial Viral and Endogenous Polypeptides. United States US 9,969,797. 2018 May.

select

Meretoja VV, Paul S, Planque SA. Erratum to: Hydrolysis and Dissolution of Amyloids by Catabodies. Methods Mol Biol. 2017;1643:E1. doi: 10.1007/978-1-4939-7180-0_16. PubMed PMID: 28836187.

select

Meretoja VV, Paul S, Planque SA. Hydrolysis and Dissolution of Amyloids by Catabodies. Methods Mol Biol. 2017;1643:111-134. doi: 10.1007/978-1-4939-7180-0_9. PubMed PMID: 28667533.

select

Planque SA, Nishiyama Y, Sonoda S, Lin Y, Taguchi H, Hara M, Kolodziej S, Mitsuda Y, Gonzalez V, Sait HB, Fukuchi K, Massey RJ, Friedland RP, O'Nuallain B, Sigurdsson EM, Paul S. Specific amyloid β clearance by a catalytic antibody construct. J Biol Chem. 2015 Apr 17;290(16):10229-41. doi: 10.1074/jbc.M115.641738. Epub 2015 Feb 27. PubMed PMID: 25724648; PubMed Central PMCID: PMC4400338.

select

Paul S, Nishiyama Y, inventors. Covalent Bioscience, Inc., assignee. Proteolytic and Covalent Antibodies. United States US 8,980,646. 2015 March.

select

Kou J, Yang J, Lim JE, Pattanayak A, Song M, Planque S, Paul S, Fukuchi K. Catalytic immunoglobulin gene delivery in a mouse model of Alzheimer's disease: prophylactic and therapeutic applications. Mol Neurobiol. 2015 Feb;51(1):43-56. doi: 10.1007/s12035-014-8691-z. Epub 2014 Apr 15. PubMed PMID: 24733587; PubMed Central PMCID: PMC4198531.

select

Paul S, Planque S, Massey RJ. Antibody Engineering. Encyclopedia of Life Sciences. In: eLS. Chichester: John Wiley & Sons Ltd; 2015. DOI 10.1002/9780470015902.a0001278.pub3. Available from: http://www.els.net.

select

Planque SA, Mitsuda Y, Chitsazzadeh V, Gorantla S, Poluektova L, Nishiyama Y, Ochsenbauer C, Morris MK, Sapparapu G, Hanson CV, Massey RJ, Paul S. Deficient synthesis of class-switched, HIV-neutralizing antibodies to the CD4 binding site and correction by electrophilic gp120 immunogen. AIDS. 2014 Sep 24;28(15):2201-11. doi: 10.1097/QAD.0000000000000392. PubMed PMID: 25022597; PubMed Central PMCID: PMC4573643.

select

Paul S, Nishiyama Y, Planque S, inventors. University of Texas System, assignee. Transthyretin Amyloid-Selective and Polyreactive Catabodies. United States patent application US 14/906,125. 2014 July.

select

Paul S, Nishiyama Y, Planque S, inventors. University of Texas System, assignee. Transthyretin Amyloid-Selective and Polyreactive Catabodies. Europe patent application EP 14826647.1. 2014 July.

select

Nishiyama Y, Taguchi H, Hara M, Planque SA, Mitsuda Y, Paul S. Metal-dependent amyloid β-degrading catalytic antibody construct. J Biotechnol. 2014 Jun 20;180:17-22. doi: 10.1016/j.jbiotec.2014.03.026. Epub 2014 Apr 1. PubMed PMID: 24698848; PubMed Central PMCID: PMC4512298.

select

Paul S, Nishiyama Y, inventors. Covalent Bioscience, Inc., assignee. Covalent Attachment of Ligands to Nucleophilic Proteins Guided by Non-Covalent Binding. Canada CA 2,520,392. 2014 May.

select

Paul S, Nishiyama Y, inventors. Covalent Bioscience, Inc., assignee. Covalent Attachment of Ligands to Nucleophilic Proteins Guided by Non-Covalent Binding. United States US 9,006,388. 2014 May.

select

Paul S, inventor. Covalent Bioscience, Inc., assignee. Lupus Antibodies for Passive Immunotherapy of HIV/AIDS. Japan JP 5552070. 2014 May.

select

Planque SA, Nishiyama Y, Hara M, Sonoda S, Murphy SK, Watanabe K, Mitsuda Y, Brown EL, Massey RJ, Primmer SR, O'Nuallain B, Paul S. Physiological IgM class catalytic antibodies selective for transthyretin amyloid. J Biol Chem. 2014 May 9;289(19):13243-58. doi: 10.1074/jbc.M114.557231. Epub 2014 Mar 19. PubMed PMID: 24648510; PubMed Central PMCID: PMC4036335.

select

Phay M, Blinder V, Macy S, Greene MJ, Wooliver DC, Liu W, Planas A, Walsh DM, Connors LH, Primmer SR, Planque SA, Paul S, O'Nuallain B. Transthyretin aggregate-specific antibodies recognize cryptic epitopes on patient-derived amyloid fibrils. Rejuvenation Res. 2014 Apr;17(2):97-104. doi: 10.1089/rej.2013.1524. PubMed PMID: 24164623.

select

Paul S, Nishiyama Y, inventors. Covalent Bioscience, Inc., assignee. Covalent Attachment of Ligands to Nucleophilic Proteins Guided by Non-Covalent Binding. Japan JP 5827003. 2014 March.

select

Paul S, Nishiyama Y, inventors. Covalent Bioscience, Inc., assignee. Covalent Attachment of Ligands to Nucleophilic Proteins Guided by Non-Covalent Binding. Japan JP 5503837. 2014 March.

select

Paul S, inventor. Covalent Bioscience, Inc., assignee. Lupus Antibodies for Passive Immunotherapy of HIV/AIDS. Canada CA 2,520,382. 2014 January.

select

Yang J, Pattanayak A, Song M, Kou J, Taguchi H, Paul S, Ponnazhagan S, Lalonde R, Fukuchi K. Muscle-directed anti-Aβ single-chain antibody delivery via AAV1 reduces cerebral Aβ load in an Alzheimer's disease mouse model. J Mol Neurosci. 2013 Feb;49(2):277-88. doi: 10.1007/s12031-012-9877-3. Epub 2012 Sep 4. PubMed PMID: 22945846; PubMed Central PMCID: PMC3545079.

select

Nishiyama Y, Paul S. Rawlings ND, Salvesen GS, editors. VIPase: antibody light chain hydrolyzing vasoactive intestinal peptide. In Handbook of Proteolytic Enzymes England: Oxford Academic Press; 2013. p.3739-3744.

select

Nishiyama Y, Planque S, Hanson CV, Massey RJ, Paul S. CD4 binding determinant mimicry for HIV vaccine design. Front Immunol. 2012;3:383. doi: 10.3389/fimmu.2012.00383. eCollection 2012. PubMed PMID: 23251137; PubMed Central PMCID: PMC3523313.

select

Planque SA, Mitsuda Y, Nishiyama Y, Karle S, Boivin S, Salas M, Morris MK, Hara M, Liao G, Massey RJ, Hanson CV, Paul S. Antibodies to a superantigenic glycoprotein 120 epitope as the basis for developing an HIV vaccine. J Immunol. 2012 Dec 1;189(11):5367-81. doi: 10.4049/jimmunol.1200981. Epub 2012 Oct 22. PubMed PMID: 23089396; PubMed Central PMCID: PMC3755593.

select

Sapparapu G, Planque S, Mitsuda Y, McLean G, Nishiyama Y, Paul S. Constant domain-regulated antibody catalysis. J Biol Chem. 2012 Oct 19;287(43):36096-104. doi: 10.1074/jbc.M112.401075. Epub 2012 Sep 4. PubMed PMID: 22948159; PubMed Central PMCID: PMC3476277.

select

Paul S, Hanson CV, Weksler M, Nishiyama Y, inventors. Coimmune, Inc., assignee. Catalytic Immunoglobulins. Japan JP 5102205. 2012 October.

select

Paul S, inventor. Covalent Bioscience, Inc., assignee. Lupus Antibodies for Passive Immunotherapy of HIV/AIDS. United States US 8,246,957. 2012 August.

select

Brown EL, Nishiyama Y, Dunkle JW, Aggarwal S, Planque S, Watanabe K, Csencsits-Smith K, Bowden MG, Kaplan SL, Paul S. Constitutive production of catalytic antibodies to a Staphylococcus aureus virulence factor and effect of infection. J Biol Chem. 2012 Mar 23;287(13):9940-9951. doi: 10.1074/jbc.M111.330043. Epub 2012 Feb 2. PubMed PMID: 22303018; PubMed Central PMCID: PMC3323049.

select

Paul S, Nishiyama Y, inventors. Covalent Bioscience, Inc., assignee. Proteolytic and Covalent Antibodies. Japan JP 4939929. 2012 March.

select

Paul S, Planque SA, Nishiyama Y, Hanson CV, Massey RJ. Nature and nurture of catalytic antibodies. Adv Exp Med Biol. 2012;750:56-75. doi: 10.1007/978-1-4614-3461-0_5. PubMed PMID: 22903666.

select

Paul S, Planque S, Nishiyama Y, Escobar M, Barnett Z, Massey RJ. Covalent vaccination and catalytic antibodies: A new way of looking at and dealing with HIV. GMHC “Treatment Issues.” June 2011. http://www.gmhc.org/files/editor/file/r_ti_0511.pdf. Print version published in POZ magazine. 2011 June; :21-25.

select

Paul S. Two-faced catalytic autoantibodies. Blood. 2011 Feb 17;117(7):2084-6. doi: 10.1182/blood-2010-12-324335. PubMed PMID: 21330481.

select

Paul S, Planque S. Antibody Engineering. Encyclopedia of Life Sciences. In: eLS. Chichester: John Wiley & Sons Ltd; 2011. DOI: 10.1002/9780470015902.a0001278.pub2.

select

Kou J, Kim H, Pattanayak A, Song M, Lim JE, Taguchi H, Paul S, Cirrito JR, Ponnazhagan S, Fukuchi K. Anti-Amyloid-β Single-Chain Antibody Brain Delivery Via AAV Reduces Amyloid Load But May Increase Cerebral Hemorrhages in an Alzheimer's Disease Mouse Model. J Alzheimers Dis. 2011;27(1):23-38. doi: 10.3233/JAD-2011-110230. PubMed PMID: 21709371; PubMed Central PMCID: PMC3560395.

select

Paul S, Planque S, Nishiyama Y, Escobar M, Hanson C. Back to the future: covalent epitope-based HIV vaccine development. Expert Rev Vaccines. 2010 Sep;9(9):1027-43. doi: 10.1586/erv.10.77. Review. PubMed PMID: 20822346; PubMed Central PMCID: PMC3043596.

select

Paul S, Planque S, Nishiyama Y. Immunological origin and functional properties of catalytic autoantibodies to amyloid beta peptide. J Clin Immunol. 2010 May;30 Suppl 1:S43-9. doi: 10.1007/s10875-010-9414-5. Review. PubMed PMID: 20454852; PubMed Central PMCID: PMC3147076.

select

Paul S, Planque S, Nishiyama Y. Beneficial catalytic immunity to abeta peptide. Rejuvenation Res. 2010 Apr-Jun;13(2-3):179-87. doi: 10.1089/rej.2009.0958. Review. PubMed PMID: 20370602; PubMed Central PMCID: PMC2946056.

select

Planque S, Salas M, Mitsuda Y, Sienczyk M, Escobar MA, Mooney JP, Morris MK, Nishiyama Y, Ghosh D, Kumar A, Gao F, Hanson CV, Paul S. Neutralization of genetically diverse HIV-1 strains by IgA antibodies to the gp120-CD4-binding site from long-term survivors of HIV infection. AIDS. 2010 Mar 27;24(6):875-84. doi: 10.1097/QAD.0b013e3283376e88. PubMed PMID: 20186035; PubMed Central PMCID: PMC2881561.

select

Nishiyama Y, Planque S, Mitsuda Y, Nitti G, Taguchi H, Jin L, Symersky J, Boivin S, Sienczyk M, Salas M, Hanson CV, Paul S. Toward effective HIV vaccination: induction of binary epitope reactive antibodies with broad HIV neutralizing activity. J Biol Chem. 2009 Oct 30;284(44):30627-42. doi: 10.1074/jbc.M109.032185. Epub 2009 Sep 2. PubMed PMID: 19726674; PubMed Central PMCID: PMC2781617.

select

Sapparapu G, Planque SA, Nishiyama Y, Foung SK, Paul S. Antigen-specific proteolysis by hybrid antibodies containing promiscuous proteolytic light chains paired with an antigen-binding heavy chain. J Biol Chem. 2009 Sep 4;284(36):24622-33. doi: 10.1074/jbc.M109.011858. Epub 2009 Jun 19. PubMed PMID: 19542217; PubMed Central PMCID: PMC2782051.

select

Paul S, Nishiyama Y, inventors. Covalent Bioscience, Inc., assignee. Covalently Reactive Transition State Analogs and Methods of use Thereof. United States US 7,524,663. 2009 April.

select

Paul S, Planque SA, Nishiyama Y, Hanson CV. A covalent HIV vaccine: is there hope for the future?. Future Virol. 2009;4(1):7-10. doi: 10.2217/17460794.4.1.7. PubMed PMID: 20333315; PubMed Central PMCID: PMC2842995.

select

Taguchi H, Planque S, Sapparapu G, Boivin S, Hara M, Nishiyama Y, Paul S. Exceptional amyloid beta peptide hydrolyzing activity of nonphysiological immunoglobulin variable domain scaffolds. J Biol Chem. 2008 Dec 26;283(52):36724-33. doi: 10.1074/jbc.M806766200. Epub 2008 Oct 30. PubMed PMID: 18974093; PubMed Central PMCID: PMC2606003.

select

Planque S, Nishiyama Y, Taguchi H, Salas M, Hanson C, Paul S. Catalytic antibodies to HIV: physiological role and potential clinical utility. Autoimmun Rev. 2008 Jun;7(6):473-9. doi: 10.1016/j.autrev.2008.04.002. Epub 2008 Apr 29. Review. PubMed PMID: 18558365; PubMed Central PMCID: PMC2527403.

select

Planque S, Escobar MA, Smith KC, Taguchi H, Nishiyama Y, Donnachie E, Pratt KP, Paul S. Covalent inactivation of factor VIII antibodies from hemophilia A patients by an electrophilic FVIII Analog. J Biol Chem. 2008 May 2;283(18):11876-86. doi: 10.1074/jbc.M800589200. Epub 2008 Mar 11. PubMed PMID: 18337255; PubMed Central PMCID: PMC2335366.

select

Taguchi H, Planque S, Nishiyama Y, Szabo P, Weksler ME, Friedland RP, Paul S. Catalytic antibodies to amyloid beta peptide in defense against Alzheimer disease. Autoimmun Rev. 2008 May;7(5):391-7. doi: 10.1016/j.autrev.2008.03.004. Epub 2008 Apr 9. Review. PubMed PMID: 18486927; PubMed Central PMCID: PMC2430036.